Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site

Jennifer Saussede-Aim1, Eva-Laure Matera, Stephanie Herveau

  • 1Laboratoire de Cytologie Analytique, Faculté de Medecine Rockefeller, 8 Avenue Rockefeller, 69008 Lyon, France. jennifer.saussede-aim@laposte.net

Anticancer Research
|August 8, 2009
PubMed

Insights

Beta3-tubulin gene expression is inducible by antimicrotubule agents. A specific vinorelbine-responsive element containing an activator protein 1 (AP-1) site was identified in the beta3-tubulin gene promoter.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Beta3-tubulin expression correlates with clinical outcomes in patients treated with microtubule-targeted agents.
  • The regulatory mechanisms governing beta3-tubulin expression are not well understood.
  • Gene promoter cloning provided new insights into beta3-tubulin regulation.

Purpose of the Study:

  • To investigate the regulation of beta3-tubulin gene expression.
  • To identify specific DNA elements responsible for the induction of beta3-tubulin.
  • To understand the role of the beta3-tubulin gene promoter in response to antimicrotubule agents.

Main Methods:

  • Beta3-tubulin gene expression was induced using antimicrotubule agents like vinorelbine and paclitaxel.
  • Successive deletions and site-directed mutagenesis were employed to analyze the beta3-tubulin gene promoter.
  • Identification of a vinorelbine-responsive element (VRE) within the promoter region.

Main Results:

  • Beta3-tubulin gene expression was induced by vinorelbine and paclitaxel.
  • A vinorelbine-responsive element containing an activator protein 1 (AP-1) site was localized in the beta3-tubulin promoter.
  • This specific AP-1 site was activated exclusively by vinorelbine exposure among the tested agents.

Conclusions:

  • The beta3-tubulin gene promoter exhibits inducible characteristics.
  • Vinorelbine specifically activates a distinct AP-1 site within the beta3-tubulin promoter, contributing to its induction.
  • These findings enhance the understanding of beta3-tubulin gene regulation in response to therapeutic agents.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...